These are top 10 stocks traded on the Robinhood UK platform in July
Stockholders of SRx Health Solutions, Inc. (NYSE:SRXH) have approved a proposal authorizing the company’s board of directors to implement a reverse stock split of its common stock at a ratio ranging from 15-to-1 to 60-to-1. The approval was granted by written consent from holders of a majority of the company’s voting power as of July 23, 2025, according to a statement in a recent SEC filing.
The board now has the discretion to determine the exact ratio and timing of the reverse split, which may be executed at any time prior to March 31, 2026. The reverse split would apply to the company’s issued and outstanding common stock, which has a par value of $0.001 per share.
On the record date, there were 33,198,807 shares of voting capital stock outstanding on an as-converted basis. The written consent was provided by stockholders holding 17,088,904 shares, representing 51.5% of the outstanding voting power. The filing notes that, as the action was taken by written consent, there were no votes against, abstentions, or broker non-votes.
SRx Health Solutions, based in Tampa, Florida, is incorporated in Delaware. The company’s shares are listed on the NYSE American under the symbol SRXH.
This information is based on a press release statement included in a recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.